SONOMA PHARMACEUTICALS INC (SNOA)
US83558L2043 - Common Stock
| MRQ (2023-12-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 2.41M | 3.82M | 7.40M | 4.22M | 3.69M | |||
| Receivables | 2.88M | 6.42M | 4.78M | 4.66M | 5.28M | |||
| Inventories | 2.96M | 2.86M | 2.66M | 2.53M | 2.18M | |||
| Other Current Assets | 4.27M | 700.00K | 1.60M | 1.58M | 1.13M | |||
| Total Current Assets | 12.50M | 13.80M | 16.43M | 12.98M | 12.28M | |||
| Non-Current Assets | ||||||||
| PPE Net | 738.00K | 910.00K | 880.00K | 1.13M | 720.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 1.38M | 1.53M | 1.54M | 880.00K | 1.55M | |||
| Total Non-Current Assets | 2.12M | 2.43M | 2.42M | 2.01M | 2.28M | |||
| TOTAL ASSETS | 14.62M | 16.23M | 18.85M | 14.99M | 14.56M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 44.00K | 430.00K | 690.00K | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 120.00K | 600.00K | 480.00K | |||
| Accrued Expenses | 2.03M | 1.72M | 1.31M | 1.03M | 1.45M | |||
| Accounts Payable | 864.00K | 840.00K | 1.64M | 1.77M | 2.07M | |||
| Other Current Liabilities | 138.00K | 730.00K | 2.06M | 690.00K | 740.00K | |||
| Total Current Liabilities | 3.07M | 3.72M | 5.82M | 4.08M | 4.73M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 1.31M | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 4.85M | 4.54M | 4.33M | 4.24M | 4.21M | |||
| Total Non-Current Liabilities | 4.85M | 4.53M | 4.33M | 5.54M | 4.21M | |||
| TOTAL LIABILITIES | 7.93M | 8.25M | 10.15M | 9.62M | 8.94M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -193.28M | -189.51M | -184.36M | -179.28M | -175.33M | |||
| Additional Paid In Capital | 202.79M | 200.90M | 197.37M | 189.22M | 186.56M | |||
| Common Shares | 2.00K | 10.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -2.82M | -3.42M | -4.31M | -4.58M | -5.61M | |||
| Shares Outstanding | 13.68M | 4.93M | 3.10M | 2.09M | 1.78M | |||
| Tangible Book Value per Share | 0.49 | 1.62 | 2.81 | 2.56 | 3.16 | |||
| Total Shareholders' Equity | 6.69M | 7.98M | 8.70M | 5.36M | 5.62M | |||
| TOTAL LIABILITIES AND EQUITY | 14.62M | 16.23M | 18.85M | 14.99M | 14.56M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.24 | N/A | |||
| Current Ratio | 4.07 | 3.71 | 2.82 | 3.18 | 2.60 | |||
| Return On Assets (ROA) | -34.72% | -31.73% | -27.00% | -26.35% | -22.73% | |||
| Return On Equity (ROE) | -75.85% | -64.54% | -58.51% | -73.69% | -58.90% | |||
All data in USD